Alerts will be sent to your verified email
Verify Email
GUJINJEC
|
Guj. Inject (Kerala)
|
Kimia Biosciences
|
Speciality Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.58 % | 24.83 % | 38.23 % |
|
5yr average Equity Multiplier
|
0.11 | 66.02 | 2.01 |
|
5yr Average Asset Turnover Ratio
|
0.45 | 1.14 | 2.86 |
|
5yr Avg Net Profit Margin
|
-175.28 % | -0.67 % | 9.1 % |
|
Price to Book
|
11.82 | 10.62 | 0.0 |
|
P/E
|
479.16 | 12.75 | 12.86 |
|
5yr Avg Cash Conversion Cycle
|
-14.62 Days | -33.97 Days | 128.49 Days |
|
Inventory Days
|
38.61 Days | 101.63 Days | 60.0 Days |
|
Days Receivable
|
0.0 | 98.68 Days | 63.56 Days |
|
Days Payable
|
156.02 Days | 171.28 Days | 27.57 Days |
|
5yr Average Interest Coverage Ratio
|
298.1 | 0.78 | 26.44 |
|
5yr Avg ROCE
|
2.0 % | 10.6 % | 54.65 % |
|
5yr Avg Operating Profit Margin
|
-279.73 % | 3.89 % | 13.99 % |
|
5 yr average Debt to Equity
|
-0.62 | 29.85 | 0.4 |
|
5yr CAGR Net Profit
|
n/a | 13.51 % | 42.22 % |
|
5yr Average Return on Assets
|
-116.01 % | -0.69 % | 18.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 74.94 % | 43.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 43.43 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Guj. Inject (Kerala)
|
Kimia Biosciences
|
Speciality Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|